关于抗老这一终极命题，谷雨找到了前沿答案

Core Insights - Gu Yu Biotechnology Group has developed a proprietary anti-aging ingredient, "Human-like Extracellular Vesicle HME," addressing the challenge of applying human-derived exosomes in cosmetics [1][2] - The new ingredient is a significant innovation in the industry, enhancing Gu Yu's portfolio alongside existing key ingredients like Aurora Licorice and Rare Ginseng Saponin CK [1][2] Industry Context - Exosomes have become a focal point for major international cosmetic brands due to their proven anti-aging, antioxidant, and repair properties [2] - The aging process is linked to the inability of the body to maintain normal cell renewal and homeostasis, which is closely regulated by intercellular communication involving exosomes [2] Technological Breakthrough - The Human-like Extracellular Vesicle HME is synthesized using biomimetic methods, accurately simulating the structure of exosomes to encapsulate and deliver key active components like miRNA and siRNA [3] - Gu Yu's research has overcome traditional challenges associated with stem cell-derived exosomes, such as aging, mutation, and contamination risks [3] Scientific Validation - The exploration of exosomes has led to significant theoretical breakthroughs, including four Nobel Prizes in the last 20 years, validating their role as effective signaling molecules [4] AI Integration - Gu Yu leverages AI technology to accelerate the analysis and selection of high-activity target genes from thousands of candidates, ensuring the efficacy of the new ingredient [5][6] - The company has achieved stable and scalable production of the Human-like Extracellular Vesicle HME, ensuring consistency across batches [6] Competitive Advantage - Gu Yu's founder defines the Human-like Extracellular Vesicle HME as a groundbreaking "cell gene-level anti-aging" ingredient, positioning it as a leading solution in the next generation of anti-aging skincare [7] - The company has established a comprehensive self-research model, controlling the entire supply chain from raw material development to production [7][8] Future Outlook - With the introduction of the Human-like Extracellular Vesicle HME, Gu Yu has launched three core self-developed ingredients within its first decade, creating a competitive barrier that is difficult for others to replicate [9] - The company plans to invest 2 billion yuan in research and development over the next decade, reflecting its commitment to scientific innovation and market differentiation [9]